jbt marel - JBTM
JBTM
Close Chg Chg %
155.13 -0.10 -0.06%
Pre-Market
155.04
-0.10 (0.06%)
Volume: 150.87K
Last Updated:
Dec 24, 2025, 12:59 PM EDT
Company Overview: jbt marel - JBTM
JBTM Key Data
| Open $155.98 | Day Range 154.65 - 156.11 |
| 52 Week Range 90.08 - 157.22 | Market Cap $8.06B |
| Shares Outstanding 51.97M | Public Float 51.17M |
| Beta 1.01 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$2.23 |
| Yield 25.70% | Dividend $0.10 |
| EX-DIVIDEND DATE Dec 15, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 477.35K |
JBTM Performance
| 1 Week | 0.47% | ||
| 1 Month | 10.38% | ||
| 3 Months | 12.93% | ||
| 1 Year | 20.82% | ||
| 5 Years | 31.69% |
JBTM Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
6
Full Ratings ➔
About jbt marel - JBTM
JBT Marel Corp. is a technology solutions provider, which engages in the food, beverage, and air transportation industries. It operates through the United States and All Other Countries geographic segments. The company was founded on May 12, 1994, and is headquartered in Chicago, IL.
JBTM At a Glance
JBT Marel Corp.
70 West Madison Street
Chicago, Illinois 60602
| Phone | 1-312-861-5900 | Revenue | 1.72B | |
| Industry | Industrial Machinery | Net Income | 85.40M | |
| Sector | Producer Manufacturing | 2024 Sales Growth | 3.621% | |
| Fiscal Year-end | 12 / 2025 | Employees | 12,200 | |
| View SEC Filings |
JBTM Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 47.922 |
| Price to Sales Ratio | 2.376 |
| Price to Book Ratio | 2.622 |
| Price to Cash Flow Ratio | 17.52 |
| Enterprise Value to EBITDA | 15.376 |
| Enterprise Value to Sales | 2.397 |
| Total Debt to Enterprise Value | 0.306 |
JBTM Efficiency
| Revenue/Employee | 141,196.721 |
| Income Per Employee | 7,000.00 |
| Receivables Turnover | 5.141 |
| Total Asset Turnover | 0.563 |
JBTM Liquidity
| Current Ratio | 3.48 |
| Quick Ratio | 3.044 |
| Cash Ratio | 2.295 |
JBTM Profitability
| Gross Margin | 36.764 |
| Operating Margin | 10.153 |
| Pretax Margin | 5.538 |
| Net Margin | 4.958 |
| Return on Assets | 2.763 |
| Return on Equity | 5.578 |
| Return on Total Capital | 3.012 |
| Return on Invested Capital | 3.43 |
JBTM Capital Structure
| Total Debt to Total Equity | 81.919 |
| Total Debt to Total Capital | 45.031 |
| Total Debt to Total Assets | 37.055 |
| Long-Term Debt to Equity | 81.149 |
| Long-Term Debt to Total Capital | 44.607 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Jbt Marel - JBTM
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 1.87B | 2.17B | 1.66B | 1.72B | |
Sales Growth
| +8.36% | +16.26% | -23.51% | +3.62% | |
Cost of Goods Sold (COGS) incl D&A
| 1.30B | 1.54B | 1.09B | 1.09B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 76.80M | 82.40M | 93.50M | 93.60M | |
Depreciation
| 34.90M | 33.40M | 30.80M | 31.60M | |
Amortization of Intangibles
| 41.90M | 47.70M | 60.50M | 57.80M | |
COGS Growth
| +9.43% | +18.72% | -29.48% | -0.01% | |
Gross Income
| 568.20M | 628.60M | 573.00M | 633.30M | |
Gross Income Growth
| +6.01% | +10.63% | -8.85% | +10.52% | |
Gross Profit Margin
| +30.39% | +28.92% | +34.47% | +36.76% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 402.10M | 434.20M | 409.60M | 458.40M | |
Research & Development
| 29.90M | 29.40M | 20.50M | 20.90M | |
Other SG&A
| 372.20M | 404.80M | 389.10M | 437.50M | |
SGA Growth
| +11.39% | +7.98% | -5.67% | +11.91% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 6.00M | 26.00M | (1.30M) | 56.50M | |
EBIT after Unusual Expense
| 160.10M | 168.40M | 164.70M | 118.40M | |
Non Operating Income/Expense
| 6.00M | 2.40M | 11.20M | 7.50M | |
Non-Operating Interest Income
| - | - | 2.60M | 23.70M | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 13.40M | 16.60M | 22.80M | 30.50M | |
Interest Expense Growth
| -26.78% | +23.88% | +37.35% | +33.77% | |
Gross Interest Expense
| 13.40M | 16.60M | 22.80M | 30.50M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 152.70M | 154.20M | 153.10M | 95.40M | |
Pretax Income Growth
| +4.95% | +0.98% | -0.71% | -37.69% | |
Pretax Margin
| +8.17% | +7.09% | +9.21% | +5.54% | |
Income Tax
| 34.30M | 23.50M | 23.50M | 10.70M | |
Income Tax - Current - Domestic
| 6.40M | 34.70M | 22.90M | 3.20M | |
Income Tax - Current - Foreign
| 30.60M | 14.60M | 22.20M | 33.30M | |
Income Tax - Deferred - Domestic
| 2.50M | (23.40M) | (21.80M) | (25.20M) | |
Income Tax - Deferred - Foreign
| (5.20M) | (2.40M) | 200.00K | (600.00K) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 118.40M | 130.70M | 129.30M | 84.60M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 118.40M | 130.70M | 129.30M | 84.60M | |
Net Income Growth
| +8.82% | +10.39% | -1.07% | -34.57% | |
Net Margin Growth
| +6.33% | +6.01% | +7.78% | +4.91% | |
Extraordinaries & Discontinued Operations
| - | - | 453.30M | 800.00K | - |
Discontinued Operations
| - | - | 453.30M | 800.00K | - |
Net Income After Extraordinaries
| 118.40M | 130.70M | 582.60M | 85.40M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 118.40M | 130.70M | 582.60M | 85.40M | |
EPS (Basic)
| 3.7 | 4.0844 | 18.2062 | 2.6688 | |
EPS (Basic) Growth
| +8.82% | +10.39% | +345.75% | -85.34% | |
Basic Shares Outstanding
| 32.00M | 32.00M | 32.00M | 32.00M | |
EPS (Diluted)
| 3.6885 | 4.0716 | 18.1495 | 2.6522 | |
EPS (Diluted) Growth
| +8.82% | +10.39% | +345.76% | -85.39% | |
Diluted Shares Outstanding
| 32.10M | 32.10M | 32.10M | 32.20M | |
EBITDA
| 242.90M | 276.80M | 256.90M | 268.50M | |
EBITDA Growth
| -1.58% | +13.96% | -7.19% | +4.52% | |
EBITDA Margin
| +12.99% | +12.74% | +15.45% | +15.59% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 150.80 | |
| Number of Ratings | 6 | Current Quarters Estimate | 1.904 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | 6.706 | |
| Last Quarter’s Earnings | 1.94 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 5.10 | Next Fiscal Year Estimate | 7.834 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 5 | 3 | 5 | 5 |
| Mean Estimate | 1.90 | 1.66 | 6.71 | 7.83 |
| High Estimates | 1.94 | 1.78 | 8.30 | 8.30 |
| Low Estimate | 1.85 | 1.57 | 6.26 | 7.07 |
| Coefficient of Variance | 2.01 | 6.56 | 13.30 | 7.42 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 3 | 3 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 0 | 1 | 2 |
| UNDERWEIGHT | 1 | 1 | 1 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Jbt Marel - JBTM
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Jbt Marel - JBTM
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Dec 12, 2025 | Olafur Steinn Gudmundsson Director | 9,980 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $150.09 per share | 1,497,898.20 |
| Jul 3, 2025 | James C. Pelletier EVP & General Counsel | 2,079 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Jessi L. Corcoran VP, Corporate Controller & CAO | 3,302 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Mary Beth Siddons EVP, President DF&H | 2,731 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $131.35 per share | 358,716.85 |
| Mar 3, 2025 | Matthew J. Meister Executive VP & CFO | 16,387 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Matthew J. Meister Executive VP & CFO | 13,060 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $117.24 per share | 1,531,154.40 |
| Mar 3, 2025 | Matthew J. Meister Executive VP & CFO | 15,324 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Roger Claessens EVP, President Poultry | 1,627 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Arni Sigurdsson President | 25,190 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Jessi L. Corcoran VP, Corporate Controller & CAO | 3,704 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $131.35 per share | 486,520.40 |
| Mar 3, 2025 | Jessi L. Corcoran VP, Corporate Controller & CAO | 3,767 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Jessi L. Corcoran VP, Corporate Controller & CAO | 3,046 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $117.24 per share | 357,113.04 |
| Mar 3, 2025 | Jesper Hjortshoj EvP, President Fish & RFS | 3,838 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Brian A. Deck CEO; Director | 121,161 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $131.35 per share | 15,914,497.35 |
| Mar 3, 2025 | Brian A. Deck CEO; Director | 123,510 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | Brian A. Deck CEO; Director | 108,131 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $117.24 per share | 12,677,278.44 |
| Mar 3, 2025 | Brian A. Deck CEO; Director | 119,277 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | James L. Marvin EVP & Chief Legal Officer | 19,703 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $131.35 per share | 2,587,989.05 |
| Mar 3, 2025 | James L. Marvin EVP & Chief Legal Officer | 20,007 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 3, 2025 | James L. Marvin EVP & Chief Legal Officer | 18,233 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $117.24 per share | 2,137,636.92 |